Mercado europeo de fabricación de células madre: tendencias de la industria y pronóstico hasta 2028

Personalice su informePersonalice su informe Compre ahoraCompre ahora Ejemplo de informe gratuitoEjemplo de informe gratuito
Hogar Medical Devices Europe Stem Cell Manufacturing Market
Solicitud de índiceSolicitud de índice Hable con el analistaHable con el analista Comprar ahoraComprar ahora Consultar antes de comprarConsultar antes Informe de muestra gratuitoInforme de muestra gratuito

Mercado europeo de fabricación de células madre: tendencias de la industria y pronóstico hasta 2028

  • Medical Devices
  • Published Report
  • Aug 2021
  • Europe
  • 350 Páginas
  • Número de tablas: 186
  • Número de figuras: 36
Comprar ahoraComprar ahora

Europe Stem Cell Manufacturing Market

Tamaño del mercado en miles de millones de dólares

Tasa de crecimiento anual compuesta (CAGR) :  % Diagram

Diagram Período de pronóstico
 2021 –2028
Diagram Tamaño del mercado (año base)
 USD 11,076.78 Million
Diagram Tamaño del mercado (año de pronóstico)
 USD 23,505.08 Million
Diagram Tasa de crecimiento anual compuesta (CAGR)
 %
Diagram Jugadoras de los principales mercados
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Solicitud de desbloqueo

>Mercado europeo de fabricación de células madre, por productos (líneas de células madre, instrumentos, consumibles y kits), aplicación (aplicaciones de investigación, aplicaciones clínicas, bancos de células y tejidos y otros), usuario final (empresas biotecnológicas y farmacéuticas, institutos de investigación e institutos académicos, bancos de células y tejidos, hospitales y centros quirúrgicos y otros), canal de distribución (ventas directas y distribuidores externos), país (Alemania, Francia, Reino Unido, Italia, España, Rusia, Bélgica, Turquía, Suiza, Países Bajos y resto de Europa), tendencias de la industria y pronóstico hasta 2028.   

Mercado europeo de fabricación de células madreAnálisis y perspectivas del mercado: mercado europeo de fabricación de células madre

Se espera que el mercado europeo de fabricación de células madre gane crecimiento de mercado en el período de pronóstico de 2021 a 2028. Data Bridge Market Research analiza que el mercado está creciendo con una CAGR del 10,1% en el período de pronóstico de 2021 a 2028 y se espera que alcance los USD 23.505,08 millones para 2028 desde USD 11.076,78 millones en 2020. La creciente prevalencia del cáncer y el trasplante de células madre, el crecimiento de nuevos avances tecnológicos para el trasplante de células madre es probable que sean los principales impulsores que impulsan la demanda del mercado en el período de pronóstico.

Las células madre son la materia prima del cuerpo que puede diferenciarse en una variedad de células, es decir, células a partir de las cuales se generan todas las demás células con funciones especializadas. Las terapias con células madre se definen como el tratamiento de una afección médica que implica el uso de cualquier tipo de células madre humanas , incluidas las células madre embrionarias y las células madre adultas para terapias alogénicas y autólogas.

La aparición de la investigación con células madre ha revelado el potencial terapéutico de las células madre y sus derivados . La fabricación exitosa de células madre y sus derivados está teniendo un impacto positivo en el ámbito de la atención sanitaria. Estos productos de células madre se utilizan para restaurar la función de tejidos y órganos dañados y para desarrollar terapias celulares basadas en células madre para el tratamiento del cáncer, trastornos hematológicos, trastornos genéticos , enfermedades autoinmunes e inflamatorias.

El aumento de la investigación y el desarrollo por parte de los actores clave de la industria para el desarrollo de productos innovadores, el apoyo del gobierno y la creciente adopción de células madre están impulsando el crecimiento del mercado. Las metodologías avanzadas presentes en el campo también están impulsando el crecimiento del mercado mundial de fabricación de células madre. Sin embargo, el alto costo de las terapias y la disponibilidad de alternativas para el tratamiento de tumores pueden restringir el mercado. La presencia de una gran cantidad de productos en desarrollo junto con las iniciativas estratégicas adoptadas por los actores del mercado están actuando como una oportunidad para el mercado. La falta de profesionales capacitados puede actuar como un desafío para el mercado.

The global stem cell manufacturing market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

Mercado europeo de fabricación de células madreStem Cell Manufacturing Market Scope and Market Size

The stem cell manufacturing market is categorized into four notable segments which are based on products, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of products, stem cell manufacturing market is segmented into stem cell lines, instruments, consumables & kits. In 2021, consumables & kits segment is expected to dominate the market due to the frequent purchase of consumables, rising stem cell research, and increasing demand for stem cell therapies
  • On the basis of application, cell manufacturing market is segmented into research applications, clinical applications, cell and tissue banking and others. In 2021, research applications segment is expected to dominate market because due to the rising focus on stem cell cytology & pathophysiology research, and growing public-private funding to support stem cell product development and commercialization.
  • On the basis of end user, stem cell manufacturing market is segmented into biotechnology & pharmaceutical companies, research institutes and academic institutes, cell banks and tissue banks, hospital & surgical centers and others. In 2021, pharmaceutical & biotechnology companies segment is expected to dominate the market due to the growing emphasis on strategic initiatives (such as acquisitions, partnerships, and collaborations) by pharma and biotech companies to expand their capabilities in stem cell research.
  • On the basis of distribution channel, stem cell manufacturing market is segmented into direct sales and third party distributors. In 2021, direct sales segment is expected to dominate the market because of large number of players in the market.

Europe Stem Cell Manufacturing Market Country Level Analysis

The stem cell manufacturing market is analysed and market size information is provided by products, application, end user and distribution channel.

The countries covered in the North Ammerica stem cell manufacturing market report are Germany, France, U.K., Italy, Spain, Russia, Belgium, Turkey, Switzerland, Netherlands, and Rest of Europe.

Germany is dominating the global stem cell manufacturing market in the Europe region due to presence of untapped opportunities in Germany for stem cell based products and increased prevalence cases of cancer in Germany.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

The Growing Adoption of Stem Cell Therapy along with Public-Private Funding are Creating Opportunities in the Stem Cell Manufacturing Market  

The stem cell manufacturing market also provides you with detailed market analysis for every country growth in particular industry with wound debridement device sales, impact of advancement in the ELISpot and FluorSpot assayand changes in regulatory scenarios with their support for the ELISpot and FluorSpot assay market. The data is available for historic period 2019 to 2020.

Competitive Landscape and Europe Stem Cell Manufacturing Market Share Analysis

Europe stem cell manufacturing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the stem cell manufacturing market.

The major companies providing the stem cell manufacturing are Thermo Fisher Scientific Inc., Merck KGaA, BD, Organogenesis Inc., Vericel Corporation, ANTEROGEN. CO., LTD., VistaGen Therapeutics, Inc., FUJIFILM Cellular Dynamics, Inc., American CryoSystem Corporation, PromoCell GmbH, Sartorius AG, ViaCyte, Inc., STEM CELL Technologies, Inc., Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, Bio-Techne, REPROCELL Inc., Catalent, Inc, Mesoblast Ltd, Astellas Pharma Inc. among others.

The strategic initiatives by market players along with new technological advancements for stem cell manufacturing is bridging the gap for various treatments.

For instance,

  • In June 2021, REPROCELL Inc. announced that it has opened new seed iPSC manufacture suite to meet the increasing demand of Ipsc-derived master cell banks. This will help the company to address the rising demand and to grow in coming years.
  • En junio de 2021, Catalent Inc. anunció que había adquirido RheinCell Therapeuics, un fabricante de células madre pluripotentes inducidas humanas. Esto ayudará a la empresa a desarrollar su proceso de terapia celular personalizada.
  • En junio de 2021, Bio-Techne anunció que había mejorado su capacidad de fabricación de ingeniería genética y terapia celular y génica. Esto ayudará a la empresa a expandir aún más su negocio.

La colaboración, las empresas conjuntas y otras estrategias de los actores del mercado están mejorando el mercado de la empresa en el mercado de fabricación de células madre, lo que también proporciona el beneficio para que la organización mejore su oferta para el mercado de fabricación de células madre.

 

SKU-

Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo

Sample Image Click on image to enlarge
  • Panel de análisis de datos interactivo
  • Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
  • Acceso de analista de investigación para personalización y consultas
  • Análisis de la competencia con panel interactivo
  • Últimas noticias, actualizaciones y análisis de tendencias
  • Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Solicitud de demostración

Tabla de contenido

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Europe stem cell manufacturing market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCTs LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. EUROPE STEM CELL MANUFACTURING MARKET: REGULATIONS
    1. REGULATORY FRAMEWORK IN THE UNITED STATES
    2. REGULATORY FRAMEWORK IN EUROPE
    3. REGULATORY FRAMEWORK IN INDIA
    4. REGULATORY FRAMEWORK IN JAPAN
  6. pestel analysis
  7. porters five forces
  8. Market Overview
    1. Drivers
      1. INCREASING PREVaLENCE OF CANCEr
      2. INCREASE INVESTMENT IN R & D
      3. increasing adoption of stem cell therapy
      4. growing biotechnology sector, along with rising healthcare expenditure
    2. restrainTs
      1. high cost associated with therapies
      2. availability of alternatives for tumor treatment
      3. adverse effects of stem cell transplant
    3. opportunities
      1. presence of pipeline products
      2. strategic initiatives by market players
      3. rising healthcare infrastructure by various countries
      4. increasing interest for personalized medicine
    4. challenges
      1. LACK OF skilled professionals
      2. STRINGENT REGULATIONs
  9. IMPACT OF COVID-19 ON EUROPE STEM CELL MANUFACTURING MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY
    4. KEY INITIATIVES BY MARKET PLAYER DURING COVID-19
    5. CONCLUSION
  10. Europe stem cell manufacturing market, By products
    1. overview
    2. consumables & kits
      1. Culture Media
      2. differentiation kits
      3. stem cell antibody arrays
      4. identification kits
      5. stem cell antibody panels
      6. stem cell primer pair panels
      7. Cytokine panels for hematopoietic stem cell expansion
      8. lineage depletion antibodies & kits
      9. others
    3. stem cell lines
      1. human cell systems
        1. INDUCED PLURIPOTENT EMBRYONIC STEM CELLS
        2. MESENCHYMAL STEM CELLS
        3. PRIMARY HUMAN CELLS
          1. FIBROBLAST
          2. EPITHELIAL
          3. ENDOTHELIAL
        4. HEMATOPOIETIC STEM CELLS
        5. NEURAL STEM CELLS
        6. CARDIAC STEM CELLS
        7. PANCREATIC STEM CELLS
        8. OTHERS
      2. rodent cell systems
        1. PLURIPOTENT MOUSE ES CELLS
        2. MOUSE EMBRYO CULTURE
        3. PMEFS
        4. MULTIPOTENT RODENT STEM CELLS
        5. MESENCHYMAL STEM CELLS
        6. NEURAL STEM CELLS
        7. OTHERS
    4. instruments
      1. BIOREACTORS & INCUBATORS
      2. cell sorters
      3. others
  11. Europe STEM CELL MANUFACTURING market, By APPLICATION
    1. overview
    2. research applications
      1. lIFE SCIENCE RESEARCH
      2. drug discovery AND development
    3. clinical applications
      1. ALLOGENIC STEM CELL THERAPY
        1. SURGERIES
        2. MUSCULOSKELETAL DISORDERS
        3. WOUNDS AND INJURIES
        4. ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
        5. OTHERS
      2. AUTOLOGOUS STEM CELL THERAPY
        1. WOUNDS & INJURIES
        2. CARDIOVASCULAR DISEASES
        3. GASTROINTESTINAL DISEASES
        4. OTHERS
    4. cell & tissue banking
    5. others
  12. Europe STEM CELL MANUFACTURING market, By END USER
    1. overview
    2. biotechnology & pharmaceutical companies
    3. RESEARCH INSTITUTES AND ACADEMIC INSTITUTES
    4. cell banks & tissue banks
    5. hospitals & surgical centers
    6. others
  13. Europe stem cell manufacturing market, By distribution channel
    1. overview
    2. DIRECT sales
    3. third party distributors
  14. EUROPE stem cell manufacturing MARKET, BY REGION
    1. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Netherlands
      6. Switzerland
      7. Spain
      8. Russia
      9. Belgium
      10. Turkey
      11. Rest of Europe
  15. EUROPE Stem Cell Manufacturing Market: COMPANY landscape
    1. company share analysis: Europe
  16. swot analysis
  17. company profile
    1. THERMO FISHER SCIENTIFIC INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    2. takeda pharmaceutical company limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Merck kgaa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. AMERICAN cryosystem corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. ANTEROGEN.CO.,LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. astellas pharma inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. BD
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    8. Bio-TECHNE
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. catalent, inc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. daiichi sankyo company, limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    11. fujifilm cellular dynamics, inc.
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. Product Portfolio
      4. Recent Developments
    12. mesoblast ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    13. organogenesis inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. promocell gmbh
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Developments
    15. reprocell inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. sartorius ag
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. stemcell technologies inc.
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Developments
    18. vericel corporation
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. viacyte, inc.
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Developments
    20. vistagen therapeutics, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  18. questionnaire
  19. related reports

Lista de Tablas

TABLE 1 Below provided are the alternatives for cancer treatment:

TABLE 2 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)

TABLE 3 EUROPE stem cell manufacturing MARKET, By products, 2019-2028 (USD million)

TABLE 4 Europe consumables & kits in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 5 EUROPE consumables & kits in stem cell manufacturing MARKET, By products, 2019-2028 (USD million)

TABLE 6 Europe stem cell lines in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 7 Europe stem cell lines in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 8 Europe human cell systems in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 9 Europe primary human cells in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 10 Europe rodent cell systems in stem cell manufacturing Market, By products, 2019-2028 (USD Million)

TABLE 11 Europe instruments in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 12 Europe instruments in stem cell manufacturing Market, By PRODUCT, 2019-2028 (USD Million)

TABLE 13 Europe stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 14 Europe research applications in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 15 Europe research applications in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 16 Europe clinical applications in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 17 Europe clinical applications in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 18 Europe allogenic stem cell therapy in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 19 Europe autologous stem cell therapy in stem cell manufacturing Market, By application, 2019-2028 (USD Million)

TABLE 20 Europe cell & tissue banking in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 21 Europe others in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 22 Europe stem cell manufacturing Market, By end user, 2019-2028 (USD Million)

TABLE 23 Europe biotechnology & pharmaceuticaL COMPANIES IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 24 Europe research institutes and academic institutes IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 25 Europe cell banks & tissue banks IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 26 Europe hospitals & surgical centers IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 27 Europe others IN STEM CELL MANUFACTURING Market, BY REGION, 2019-2028 (USD Million)

TABLE 28 Europe stem cell manufacturing Market, By DISTRIBUTION CHANNEL, 2019-2028 (USD Million)

TABLE 29 Europe Direct sales in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 30 Europe third party distributors in stem cell manufacturing Market, By region, 2019-2028 (USD Million)

TABLE 31 Europe Stem Cell Manufacturing Market, By country, 2019-2028 (USD Million)

TABLE 32 EUROPE STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 33 Europe Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 34 Europe Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 35 Europe Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 36 Europe Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 37 Europe Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 38 Europe Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 39 Europe Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 40 Europe Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 41 Europe Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 42 Europe Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 43 Europe Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 44 Europe Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 45 Europe Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 46 GERMANY STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 47 Germany Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 48 Germany Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 49 Germany Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 50 Germany Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 51 Germany Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 52 Germany Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 53 Germany Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 54 Germany Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 55 Germany Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 56 Germany Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 57 Germany Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 58 Germany Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 59 Germany Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 FRANCE STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 61 France Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 62 France Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 63 France Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 64 France Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 65 France Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 66 France Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 67 France Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 68 France Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 69 France Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 70 France Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 71 France Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 72 France Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 73 France Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 74 U.K. STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 75 U.K. Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 76 U.K. Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 77 U.K. Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 78 U.K. Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 79 U.K. Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 80 U.K. Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 81 U.K. Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 82 U.K. Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 83 U.K. Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 84 U.K. Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 85 U.K. Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 86 U.K. Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 87 U.K. Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 88 ITALY STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 89 Italy Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 90 Italy Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 91 Italy Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 92 Italy Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 93 Italy Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 94 Italy Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 95 Italy Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 96 Italy Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 97 Italy Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 98 Italy Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 99 Italy Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 100 Italy Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 101 Italy Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 102 NETHERLAND STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 103 Netherland Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 104 Netherland Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 105 Netherland Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 106 Netherland Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 107 Netherland Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 108 Netherland Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 109 Netherland Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 110 Netherland Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 111 Netherland Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 112 Netherland Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 113 Netherland Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 114 Netherland Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 115 Netherland Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 116 SWITZERLAND STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 117 Switzerland Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 118 Switzerland Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 119 Switzerland Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 120 Switzerland Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 121 Switzerland Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 122 Switzerland Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 123 Switzerland Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 124 Switzerland Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 125 Switzerland Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 126 Switzerland Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 127 Switzerland Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 128 Switzerland Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 129 Switzerland Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 130 SPAIN STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 131 Spain Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 132 Spain Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 133 Spain Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 134 Spain Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 135 Spain Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 136 Spainstruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 137 Spain Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 138 Spain Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 139 Spain Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 140 Spain Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 141 Spain Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 142 Spain Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 143 Spain Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 144 RUSSIA STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 145 Russia Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 146 Russia Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 147 Russia Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 148 Russia Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 149 Russia Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 150 Russia Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 151 Russia Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 152 Russia Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 153 Russia Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 154 Russia Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 155 Russia Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 156 Russia Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 157 Russia Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 158 BELGIUM STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 159 Belgium Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 160 Belgium Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 161 Belgium Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 162 Belgium Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 163 Belgium Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 164 Belgium Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 165 Belgium Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 166 Belgium Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 167 Belgium Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 168 Belgium Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 169 Belgium Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 170 Belgium Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 171 Belgium Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 172 TURKEY STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

TABLE 173 Turkey Consumables & kITS in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 174 Turkey Stem Cell Lines in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 175 Turkey Human Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 176 Turkey Primary Human Cells in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 177 Turkey Rodent Cell Systems in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 178 Turkey Instruments in Stem Cell Manufacturing Market, By Products, 2019-2028 (USD Million)

TABLE 179 Turkey Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 180 Turkey Research Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 181 Turkey Clinical Applications in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 182 Turkey Allogenic Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 183 Turkey Autologous Stem Cell Therapy in Stem Cell Manufacturing Market, By Application, 2019-2028 (USD Million)

TABLE 184 Turkey Stem Cell Manufacturing Market, By End User, 2019-2028 (USD Million)

TABLE 185 Turkey Stem Cell Manufacturing Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 186 REST OF EUROPE STEM CELL MANUFACTURING MARKET, BY Products, 2019-2028 (USD MILLION)

Lista de figuras

FIGURE 1 Europe stem cell manufacturing market: segmentation

FIGURE 2 Europe stem cell manufacturing market: data triangulation

FIGURE 3 Europe stem cell manufacturing market: DROC ANALYSIS

FIGURE 4 Europe stem cell manufacturing market : Europe vs REGIONAL MARKET ANALYSIS

FIGURE 5 Europe stem cell manufacturing market : COMPANY RESEARCH ANALYSIS

FIGURE 6 Europe stem cell manufacturing market: INTERVIEW DEMOGRAPHICS

FIGURE 7 Europe stem cell manufacturing market: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE stem cell manufacturing MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 Europe stem cell manufacturing market: vendor share analysis

FIGURE 10 Europe stem cell manufacturing market: SEGMENTATION

FIGURE 11 increasing adoption of stem cell therapy is expected to drive THE Europe stem cell manufacturing market IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 consumables & kits segment is expected to account for the largest share of the Europe stem cell manufacturing market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTs, OPPORTUNITIES AND CHALLENGES OF EUROPE stem cell manufacturing MARKET

FIGURE 14 New Cancer Cases Worldwide in 2018

FIGURE 15 EUROPE stem cell manufacturing MARKET, By products, 2020

FIGURE 16 EUROPE stem cell manufacturing MARKET: BY products, 2021-2028 (USD million )

FIGURE 17 EUROPE stem cell manufacturing MARKET: BY products, CAGR (2021-2028)

FIGURE 18 EUROPE stem cell manufacturing MARKET: BY products, LIFELINE CURVE

FIGURE 19 EUROPE stem cell manufacturing MARKET, By application, 2020

FIGURE 20 EUROPE stem cell manufacturing MARKET: BY application, 2021-2028 (USD million )

FIGURE 21 EUROPE stem cell manufacturing MARKET: BY application, CAGR (2021-2028)

FIGURE 22 EUROPE stem cell manufacturing MARKET: BY application, LIFELINE CURVE

FIGURE 23 EUROPE stem cell manufacturing MARKET, By end user, 2020

FIGURE 24 EUROPE stem cell manufacturing MARKET: BY end user, 2021-2028 (USD million )

FIGURE 25 EUROPE stem cell manufacturing MARKET: BY end user, CAGR (2021-2028)

FIGURE 26 EUROPE stem cell manufacturing MARKET: BY end user, LIFELINE CURVE

FIGURE 27 EUROPE stem cell manufacturing MARKET, By distribution channel, 2020

FIGURE 28 EUROPE stem cell manufacturing MARKET: BY distribution channel, 2021-2028 (USD million )

FIGURE 29 EUROPE stem cell manufacturing MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 30 EUROPE stem cell manufacturing MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 31 EUROPE Stem Cell Manufacturing Market: SNAPSHOT (2020)

FIGURE 32 EUROPE STEM CELL MANUFACTURING Market: BY COUNTRY (2020)

FIGURE 33 EUROPE STEM CELL MANUFACTURING Market: BY COUNTRY (2021 & 2028)

FIGURE 34 EUROPE STEM CELL MANUFACTURING Market: BY COUNTRY (2020 & 2028)

FIGURE 35 EUROPE STEM CELL MANUFACTURING Market: BY Products (2021-2028)

FIGURE 36 Europe Stem Cell Manufacturing Market: company share 2020 (%)

Ver información detallada Right Arrow

Metodología de investigación

La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.

La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.

Personalización disponible

Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados ​​en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.

Preguntas frecuentes

The market is segmented based on , By Products (Stem Cell Lines, Instruments, Consumables & Kits), Application (Research Applications, Clinical Applications, Cell and Tissue Banking and Others),End User (Biotechnology & Pharmaceutical Companies, Research Institutes and Academic Institutes, Cell Banks and Tissue Banks, Hospital & Surgical Centers and Others), Distribution Channel (Direct Sales and Third Party Distributor), Country (Germany, France, U.K., Italy, Spain, Russia, Belgium, Turkey, Switzerland, Netherlands, and Rest of Europe ) Industry Trends and Forecast to 2028.    .
The Europe Stem Cell Manufacturing Market size was valued at USD 11076.78 USD Million in 2020.
The Europe Stem Cell Manufacturing Market is projected to grow at a CAGR of 10.1% during the forecast period of 2021 to 2028.

Explorar páginas relacionadas

Banner